Search results
Compugen stock target cut on colorectal cancer trial woes By Investing.com
Investing.com· 7 days agoThe revision follows the announcement that Compugen's combination therapy involving COM701 and...
Guardant Health's blood test to detect deadly colon cancer is under review by the FDA
Quartz· 4 days agoA U.S. Food and Drug Administration (FDA) advisory committee is meeting today to review a new blood...
Personal View: What I wish Ohioans knew about screening for colon cancer
Crain's Cleveland Business· 6 days agoIncreased dialogue around this spike in colorectal cancer is welcomed and much-needed, given that recent surveys show about 30% of Ohioans haven’t received ...
Tanya Sumner Dies: Former News Anchor At Indianapolis ABC Affiliate WRTV Was 53
Deadline via Yahoo News· 1 day agoTanya Sumner, a former Indianapolis ABC affiliate WRTV news anchor, has died. She was 53. The...
Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok
The Wall Street Journal· 3 days agoShares of Guardant Health were up 8% Friday morning after an advisory panel to the U.S. Food and...
2 conflicting colonoscopy guidelines
Becker's ASC Review· 5 days agoThe jury is still out on several guidelines regarding screening colonoscopies, despite rising colorectal cancer rates. Colorectal < ...
Panel recommends blood test to detect colon cancer for FDA approval
UPI· 4 days agoMay 23 (UPI) -- A panel of U.S. Food and Drug Administration advisers on Thursday recommended...
Quarterbacking Care for Cancer Survivors
Medscape· 3 days agoPrimary care clinicians face challenges in knowledge and care coordination as they care for a rising number of cancer survivors in the United States,...
Peninsula cancer test maker lands key nod from FDA panel, a step toward a big payday - San Francisco...
The Business Journals· 3 days agoShares of Guardant Health Inc. closed Friday more than 13% higher day-over-day, after the Palo Alto...
Guardant wins FDA AdCom backing for colon cancer test
Medical Device Network via Yahoo Finance· 3 days agoThe FDA AdCom voted 7-2 in favour of the Shield test stating that the test’s potential benefits...
